MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Sosandar rises; Boots buys MyHealthChecked unit

ALN

The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Sosandar PLC, up 3.8% at 5.45 pence, 12-month range 4.50p-11.42p. The fashion firm says it has returned to revenue growth and is trading in line with market expectations. For the half-year to September, it expects to report a revenue increase of 15% to £18.7 million from £16.2 million, though a widened pretax loss of £1.1 million from £700,000. The loss is in line with expectations and represents the usual ‘second half weighting’ of profit and the hit from a cyber incident at Marks & Spencer Group PLC. Sosandar products are available through the M&S online offering. Sosandar says it is trading in line with expectations for annual revenue and pretax profit. It puts market expectations at £43.6 million for revenue and £400,000 for pretax profit. For the year ended March, Sosandar had reported revenue of £37.1 million and a pretax loss of £67,00.

----------

Fevertree Drinks PLC, up 5.3% at 828.57p, 12-month range 608.50p-1,020.00p. Jefferies raises the mixers maker to ’buy’ from ’hold’. It increases its price target to 1,100p from 900p.

----------

AIM - LOSERS

----------

MyHealthChecked PLC, down 22% at 7.80p, 12-month range 6.12p-21.00p. Shares hit this 12-month low on Tuesday as the home-testing healthcare products firm strikes a deal to sell its trading subsidiary Concepta Diagnostics Ltd to retailer Boots UK Ltd for £2.4 million. MyHealthChecked will be a cash shell when the deal concludes. ‘Concepta distributes and commercialises a range of at-home healthcare and wellness tests and has developed an accompanying proprietary digital platform. The Company has worked closely with Boots to develop its wellness portfolio and digital offering since its launch in May 2023 and has developed the platform to meet Boots’ requirements since the relationship began in May 2021,’ MyHealthChecked says. MyHealthChecked believes Concepta is likely to be loss-making for the foreseeable future so a sale is in the best interests of shareholders. Shareholders will vote on the disposal at a general meeting on November 4.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.